Vancomycin-resistant enterococci risk factors: Difference between revisions
Hardik Patel (talk | contribs) Created page with "__NOTOC__ {{Vancomycin-resistant enterococci}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Ove..." |
Hardik Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Vancomycin-resistant enterococci}} | {{Vancomycin-resistant enterococci}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
Prior treatment with | Prior treatment with [[antibiotic]]s is common in nearly all patients colonized or infected with MDR enterococci. [[Clindamycin]], cephalosporin,[[aztreonam]], [[ciprofloxacin]], [[aminoglycoside]], and [[metronidazole]] use is equally or more often associated with colonization or infection with MDR enterococci than vancomycin use. Other risk factors include prolonged hospitalization, high severity of illness score, intraabdominal surgery, renal insufficiency, enteral tube feedings, and exposure to specific hospital units, nurses, or contaminated objects and surfaces within patient-care areas. | ||
==Risk Factors== | |||
The following persons are at an increased risk becoming infected with VRE: | |||
*Persons who have been previously treated with [[vancomycin]] and combinations of other antibiotics such as [[penicillin]] and [[gentamicin]]. | |||
*Persons who are hospitalized, particularly when they receive antibiotic treatment for long periods of time. | |||
*Persons with weakened immune systems such as patients in Intensive Care Units, or in cancer or transplant wards. | |||
*Persons who have undergone surgical procedures such as abdominal or chest surgery. | |||
*Persons with medical devices that stay in for some time such as urinary catheters or central intravenous catheters. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]]{{WH}} | [[Category:Infectious disease]]{{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 19:22, 14 December 2012
|
Vancomycin-resistant enterococci Microchapters |
|
Differentiating Vancomycin-Resistant Enterococci from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant enterococci risk factors On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant enterococci risk factors |
|
Directions to Hospitals Treating Vancomycin-resistant enterococci |
|
Risk calculators and risk factors for Vancomycin-resistant enterococci risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prior treatment with antibiotics is common in nearly all patients colonized or infected with MDR enterococci. Clindamycin, cephalosporin,aztreonam, ciprofloxacin, aminoglycoside, and metronidazole use is equally or more often associated with colonization or infection with MDR enterococci than vancomycin use. Other risk factors include prolonged hospitalization, high severity of illness score, intraabdominal surgery, renal insufficiency, enteral tube feedings, and exposure to specific hospital units, nurses, or contaminated objects and surfaces within patient-care areas.
Risk Factors
The following persons are at an increased risk becoming infected with VRE:
- Persons who have been previously treated with vancomycin and combinations of other antibiotics such as penicillin and gentamicin.
- Persons who are hospitalized, particularly when they receive antibiotic treatment for long periods of time.
- Persons with weakened immune systems such as patients in Intensive Care Units, or in cancer or transplant wards.
- Persons who have undergone surgical procedures such as abdominal or chest surgery.
- Persons with medical devices that stay in for some time such as urinary catheters or central intravenous catheters.